Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrity Bio is a contract development and manufacturing organization (CDMO) specializing in the formulation and GMP fill-finish of biologics. Based in Camarillo, California, the company is recognized for its expertise in handling hard-to-formulate large molecules, including proteins, antibodies, lipid nanoparticles, and vaccines. Integrity Bio offers proprietary technologies such as LyoTip, a one-step reconstitution system for lyophilized products, and a high-concentration formulation platform for subcutaneous delivery. In 2021, the company was acquired by Curia to expand its biologics drug product capabilities and West Coast presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrity Biosolution.